ArticleOpen forum infectious diseases2018

Sofosbuvir-Based Direct-Acting Antiviral Therapies for HCV in People Receiving Opioid Substitution Therapy: An Analysis of Phase 3 Studies.

Jason Grebely et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.